Subsequent studies have shown that Tregs from pediatric type 2 AIH patients display impaired capacity to control the proliferation of CD4+ and CD8+ effector T-cells, and reduced numbers of Tregs have been found in AIH patients [15,16,17,93]. This evidence concerns the gene CD4 and autoimmune hepatitis.